QTC Management competitors

Mark S Ordan is a Chief Executive Officer at MEDNAX INC, Board Member at Chamber Of Commerce Of The United States Of America, and Board Member at Fidelity & Trust Bank. He has experience at Goldman Sachs and has worked as Board Member at WASHINGTON PRIME GROUP INC., President/CEO at MILLS CORP, and Trustee at Federal Realty Invsmt Trust. Mark works or has worked as BOARD MEMBER at International Center for Research on Women, BOARD MEMBER at The Economic Club of Washington DC, and BOARD MEMBER at Seed Capital. He studied at Vassar College and Harvard Business School.

Kathy J. Warden is an American business executive who serves as chief executive officer and president of Northrop Grumman, as of 2019.

Steve Rusckowski is Chairman, President and Chief Executive Officer of Quest Diagnostics. Since joining Quest Diagnostics as President and Chief Executive Officer in May 2012, Mr. Rusckowski has focused on transforming the company, based on its compelling vision of “Empowering better health with diagnostic insights.” Under his leadership, the company has refocused on its core diagnostic information services business, sold non-core assets, delivered disciplined deployment, including share repurchases and acquisitions, and simplified its organizational structure to better serve customers by removing complexity, speeding decision making and empowering employees. He was elected Chairman of the Board in December 2016. Prior to joining Quest Diagnostics, Mr. Rusckowski was CEO of Philips Healthcare, which became the largest unit of Royal Philips Electronics under his leadership. He joined Philips in 2001 when it acquired the Healthcare Solutions Group he was leading at Hewlett-Packard/Agilent Technologies. Mr. Rusckowski is a member of the Board of Directors of Project Hope, a global health education and humanitarian assistance organization. He is also a member of the Board of Directors of the American Clinical Laboratory Association, and served as its Chairman from 2014 to 2017. Mr. Rusckowski earned a Master of Science degree in Management from the Massachusetts Institute of Technology’s Sloan School of Management and a Bachelor of Science degree in Mechanical Engineering from Worcester Polytechnic Institute.

John F. Sheridan has served as our President and Chief Executive Officer since March 2019 and as a member of our Board of Directors since June 2019. Prior to joining our company, Mr. Sheridan served as Chief Operating Officer of Rapiscan Systems, Inc., a provider of security equipment and systems, from March 2012 to February 2013. Mr. Sheridan served as Executive Vice President of Research and Development and Operations for Volcano Corporation (NASDAQ: VOLC), a medical technology company, from November 2004 to March 2010. From May 2002 to May 2004, Mr. Sheridan served as Executive Vice President of Operations at CardioNet, Inc., a medical technology company. From March 1998 to May 2002, he served as Vice President of Operations at Digirad Corporation, a medical imaging company. Mr. Sheridan holds a B.S. in Chemistry from the University of West Florida and an M.B.A. from Boston University.

Lewis Von Thaer (born c. 1961) is an American business executive. He serves as President and CEO of Battelle Memorial Institute, a Columbus, Ohio-based nonprofit science and technology company. He previously served as the Chief Executive Officer of DynCorp, a McLean, Virginia-based private military contractor.

Mr. James E. Fantus is a President and Chief Executive Officer at CLINICAL LABORATORY PARTNERS and is based in United States.

Crispin Teufel is a Board Member at Bellerophon Therapeutics; Chairman Of The Board at German American Chamber of Commerce of the Southern US, Inc.; and Chief Executive Officer at LINCARE HOLDINGS INC and is based in Washington, D.C.. He has worked as Head of IFRS Competence Center & External Reporting at Linde, Intern at Rosenfelt Christensen & West Engineering A/S, and Chief Financial Officer at LINCARE HOLDINGS INC. Crispin studied at University of Chicago Booth School of Business between 2018 and 2019; Saïd Business School, University of Oxford between 2009 and 2009; and Ministry of Finance State of Hessen between 2005 and 2005.

Jeffrey L. McWaters is a Chief Executive Officer at AMERIGROUP CORP and is based in Virginia Beach, Virginia.

As Chief Executive Officer, Daniel Baker is leading HealthDrive’s dedicated team in industry innovation and expansion. Baker was elected CEO in September 2017 after serving as HealthDrive’s Chief Operating Officer for four years. Prior to joining HealthDrive, Dan worked for Omnicare, a provider of pharmacy services to the long-term care industry, for ten years. In his role as Regional Vice President, he managed ten pharmacy operations with an annual revenue of $550 million and led the turnaround of challenged operating units. Mr. Baker has a B.S. in Chemistry and a Minor in Economics from Georgetown University.